Phase 1
Completed N=12
Safety Evaluation of Advantage Anti-Caries Varnish
Source: ClinicalTrials.gov NCT02645617 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcomePrimary: Soft Tissue — 0 Participants
Summary
The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Soft Tissue |
— | — |
| SECONDARY Adverse Events |
— | — |
Eligibility Criteria
Inclusion Criteria
- Healthy
Exclusion Criteria
- Weight less than 15 kg or hypersensitivity to iodine
Data sourced from ClinicalTrials.gov (NCT02645617). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.